These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7524924)

  • 21. The presence of cation-dependent proteases for insulin-like growth factor binding proteins does not alter the size distribution of insulin-like growth factors in pregnancy.
    Davies SC; Holly JM; Coulson VJ; Cotterill AM; Abdulla AF; Whittaker PG; Chard T; Wass JA
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):501-6. PubMed ID: 1716187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors.
    Baxter RC; Daughaday WH
    J Clin Endocrinol Metab; 1991 Oct; 73(4):696-702. PubMed ID: 1716259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.
    Bond JJ; Meka S; Baxter RC
    J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic potential of miR-483 family for IGF-II producing non-islet cell tumor hypoglycemia.
    Nagao M; Fukuda I; Asai A; Esguerra JLS; Hizuka N; Eliasson L; Sugihara H
    Eur J Endocrinol; 2021 Jan; 184(1):41-49. PubMed ID: 33112286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.
    van Buul-Offers SC; Bloemen RJ; Reijnen-Gresnigt MG; van Leiden HA; Hoogerbrugge CM; Van den Brande JL
    J Endocrinol; 1994 Oct; 143(1):191-8. PubMed ID: 7525829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
    Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
    Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
    Miraki-Moud F; Grossman AB; Besser M; Monson JP; Camacho-Hübner C
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3819-23. PubMed ID: 15840753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.
    Zapf J; Walter H; Froesch ER
    J Clin Invest; 1981 Nov; 68(5):1321-30. PubMed ID: 7028787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
    Plikat K; Reichle A; Elmlinger MW; Schölmerich J
    Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development.
    Lee CY; Bazer FW; Etherton TD; Simmen FA
    Endocrinology; 1991 May; 128(5):2336-44. PubMed ID: 1708333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity.
    Fielder PJ; Thordarson G; Talamantes F; Rosenfeld RG
    Endocrinology; 1990 Nov; 127(5):2270-80. PubMed ID: 1699743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH).
    Teale JD; Marks V
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):491-8. PubMed ID: 9876347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
    Liu F; Baxter RC; Hintz RL
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia.
    Cotterill AM; Holly JM; Davies SC; Coulson VJ; Price PA; Wass JA
    J Endocrinol; 1991 Nov; 131(2):303-11. PubMed ID: 1720806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.
    Enjoh T; Hizuka N; Perdue JF; Takano K; Fujiwara H; Higashihashi N; Marumoto Y; Fukuda I; Sakano K
    J Clin Endocrinol Metab; 1993 Aug; 77(2):510-7. PubMed ID: 7688378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia.
    Setoyama T; Miyamoto S; Horimatsu T; Funakoshi T; Nikaido M; Kodama Y; Minamiguchi S; Yamabata T; Muto M; Chiba T
    Cancer Biol Ther; 2014; 15(12):1588-92. PubMed ID: 25535894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
    Bang P; Brismar K; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional modulation of canine insulin-like growth factors and their binding proteins.
    Maxwell A; Butterwick R; Yateman M; Batt RM; Cotterill A; Camacho-Hübner C
    J Endocrinol; 1998 Jul; 158(1):77-85. PubMed ID: 9713329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serum.
    Daughaday WH; Trivedi B
    J Clin Endocrinol Metab; 1992 Aug; 75(2):641-5. PubMed ID: 1379260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.